Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa 2b administered every 4 weeks plus ribavirin in interferon alfa-naïve patients with genotype 2/3 chronic hepatitis C https://kusajili.com:443/Trial/8njUp9wdw02KDo0ufswCNw%24an-open-label-randomized-multicenter-active-controlled-dose-ranging-study-to-evaluate-the-safety-and-efficacy-of-albinterferon-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message